Holen Sie sich die Stockscreener-App
13.07
0.38%
-0.0601
Schlusskurs vom Vortag:
$13.13
Offen:
$13.13
24-Stunden-Volumen:
526.94K
Relative Volume:
0.25
Marktkapitalisierung:
$1.99B
Einnahmen:
$177.28M
Nettoeinkommen (Verlust:
$-195.24M
KGV:
-9.7537
EPS:
-1.34
Netto-Cashflow:
$-114.54M
1W Leistung:
-2.10%
1M Leistung:
+2.19%
6M Leistung:
+58.74%
1J Leistung:
+166.94%
1-Tages-Spanne:
$12.82
$13.20
1-Wochen-Bereich:
$12.51
$14.47
52-Wochen-Spanne:
$4.27
$14.47
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Vergleichen Sie ADPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
13.06 | 2.00B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.41 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.14 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.16 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
716.16 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
325.68 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - Yahoo Finance
Adaptive Biotechnologies Corp. Hits New 52-Week High at $14.27 - Markets Mojo
Is Adaptive Biotechnologies Corporation trending in predictive chart modelsJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Tools to assess Adaptive Biotechnologies Corporation’s risk profileMarket Sentiment Review & Daily Momentum Trading Reports - newser.com
Adaptive Biotechnologies Corp. Hits New 52-Week High of $13.90 - Markets Mojo
Real time alert setup for Adaptive Biotechnologies Corporation performanceStop Loss & Free AI Powered Buy and Sell Recommendations - newser.com
Statistical indicators supporting Adaptive Biotechnologies Corporation’s strengthWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Adaptive Biotechnologies Corp. Hits New 52-Week High of $13.79 - Markets Mojo
Adaptive Biotechnologies Corp. Hits Day High with 7.41% Surge - Markets Mojo
US Stocks Recap: Does Adaptive Biotechnologies Corporation have a sustainable dividendIndex Update & Reliable Intraday Trade Alerts - خودرو بانک
Is Adaptive Biotechnologies Corporation stock poised for growthNew Guidance & Breakout Confirmation Trade Signals - newser.com
Identifying reversal signals in Adaptive Biotechnologies Corporation2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Can volume confirm reversal in Adaptive Biotechnologies CorporationJuly 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Adaptive Biotechnologies stock hits 52-week high at $13.73 By Investing.com - Investing.com South Africa
Adaptive Biotechnologies stock hits 52-week high at $13.73 - Investing.com
Aug Opening: Is Adaptive Biotechnologies Corporation stock good for income investors2025 Fundamental Recap & Precise Swing Trade Entry Alerts - خودرو بانک
Adaptive Biotechnologies Corporation stock retracement – recovery analysisPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Voya Investment Management LLC Has $14.90 Million Position in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Trading 7.5% HigherWhat's Next? - MarketBeat
How sentiment analysis helps forecast Adaptive Biotechnologies Corporation2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
Adaptive Biotechnologies Corporation stock trend forecast2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
Key metrics from Adaptive Biotechnologies Corporation’s quarterly dataIndex Update & Reliable Intraday Trade Plans - newser.com
Rate Cut: Will Adaptive Biotechnologies Corporation outperform tech stocksJuly 2025 PostEarnings & Weekly Breakout Watchlists - خودرو بانک
Jacobs Levy Equity Management Inc. Sells 33,002 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
How to manage a losing position in Adaptive Biotechnologies CorporationPortfolio Return Report & Growth-Oriented Investment Plans - newser.com
How to escape a deep drawdown in Adaptive Biotechnologies CorporationEarnings Miss & Real-Time Chart Breakout Alerts - newser.com
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year HighShould You Buy? - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 52-Week High – Time to Buy? - Defense World
Adaptive Biotechnologies stock hits 52-week high at $13.53 By Investing.com - Investing.com Nigeria
Published on: 2025-09-12 01:32:59 - Newser
What does recent volatility data suggest for Adaptive Biotechnologies Corporation2025 Market Overview & Verified Swing Trading Watchlists - Newser
Adaptive Biotechnologies stock hits 52-week high at $13.53 - Investing.com
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.24%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):